Cargando…
Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
Autores principales: | Huang, Zhen, Chen, Hui, Wang, Shenglin, Wei, Hongxiang, Wang, Xinwen, Shen, Rongkai, Wang, Yunqing, Lin, Rongjin, Lin, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444229/ https://www.ncbi.nlm.nih.gov/pubmed/34539420 http://dx.doi.org/10.3389/fphar.2021.753231 |
Ejemplares similares
-
NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
por: Huang, Zhen, et al.
Publicado: (2021) -
Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
por: Huang, Zhen, et al.
Publicado: (2021) -
Hypoxia increases the expression of stem cell markers in human osteosarcoma cells
por: Lin, Jinluan, et al.
Publicado: (2021) -
The Clinical Significance of the Expression of FEN1 in Primary Osteosarcoma
por: Zhong, Guangxian, et al.
Publicado: (2021) -
Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis
por: Wei, Hongxiang, et al.
Publicado: (2022)